Novo Nordisk's New CEO Aims for Cost Cuts Amid Market Challenges
Novo Nordisk's new CEO Mike Doustdar outlines plans for cost-cutting amid stock challenges and market skepticism.
Novo Nordisk's new CEO Mike Doustdar outlines plans for cost-cutting amid stock challenges and market skepticism.
Novo Nordisk's new CEO Mike Doustdar outlines plans for cost-cutting amid stock challenges and market skepticism.